AAS
BIAF icon

Ameritas Advisory Services’s bioAffinity Technologies BIAF Stock Holding History

Ameritas Advisory Services’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.83K Buy
+1,000
New +$1.61K ﹤0.01% 992

Other funds holding BIAF

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $5.87B AUM 24.95% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ameritas Advisory Services's BIAF Position: Q1 2026 in Review

Ameritas Advisory Services opened a new position in bioAffinity Technologies (BIAF) in Q1 2026: 1,000 shares worth $3.83K. The stake represents ﹤0.01% of the portfolio and ranks #992 among its holdings.

14 funds tracked by Wall St. Rank hold BIAF as of Q1 2026.

  • Ameritas Advisory Services held 1,000 shares of bioAffinity Technologies worth $3.83K as of Q1 2026.
  • bioAffinity Technologies was a new Ameritas Advisory Services position in Q1 2026.
  • bioAffinity Technologies made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q1 2026, its #992 holding.
  • 14 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q1 2026.

Based on Ameritas Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.